EN DE
STOCK COMPARISON

Jiangsu Hengrui Medicine Co vs Sun Pharmaceutical Industries: Fair Value & Quality

Both stocks run through our valuation models. Here is how Jiangsu Hengrui Medicine Co (600276) and Sun Pharmaceutical Industries (SUNPHARMA) compare, as of Aug 8, 2026.

As of Aug 8, 2026, Fair Value Calculator sees Sun Pharmaceutical Industries as the less overvalued of the two: Jiangsu Hengrui Medicine Co trades at ¥52.11 versus a fair value of ¥25.94 (-50%), while Sun Pharmaceutical Industries trades at ₹1,951 versus ₹1,781 (-9%).
Jiangsu Hengrui Medicine Co
600276.SHG · CNY · Health Care
-50%
upside to fair value
overvalued
Price¥52.11
Fair Value¥25.94
Quality59/100
Sun Pharmaceutical Industries
SUNPHARMA.NSE · INR · Health Care
-9%
upside to fair value
fairly valued
Price₹1,951
Fair Value₹1,781
Quality69/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Jiangsu Hengrui Medicine CoSun Pharmaceutical Industries
Valuation
43.6×P/E (TTM)40.5×
10.84×P/S (TTM)7.93×
5.76×P/B5.55×
33.0×EV/EBITDA27.7×
0.93×PEG1.04×
0.4%Dividend yield0.8%
¥0.20Dividend per share₹16.00
Profitability
25%Net margin20%
32%Operating margin19%
15%Return on equity15%
9%Return on assets8%
Growth
13%Revenue growth (YoY)13%
13.9%Avg. growth/yr (3Y)10.0%
2.5%Avg. growth/yr (5Y)11.8%
Balance & size
$52BMarket cap$49B
healthyGrowth qualityhealthy

Sun Pharmaceutical Industries leads: 6 to 7 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Jiangsu Hengrui Medicine Coof which business quality 68 · market factors 42 Sun Pharmaceutical Industriesof which business quality 65 · market factors 74
ProfitabilityMargins and returns on capital today
63
58
Quality GrowthAre margins and returns improving?
41
41
CashflowEarnings quality: real cash, not paper profit
82
62
Fin. StrengthBalance sheet, leverage, solvency risk
100
87
InvestmentDisciplined investing over empire-building
27
51
Low VolatilityCalm price path (market factor)
78
96
MomentumPrice trend over the last 3–12 months (market factor)
30
58
52W MomentumDistance to the 52-week high (market factor)
23
76
Net IssuanceBuybacks instead of dilution
64
81

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Jiangsu Hengrui Medicine Co

DCF Models¥37.11
Earnings-Based¥21.29
Dividend Discount¥3.82
Multiples¥22.37
Asset-Based¥6.44
Growth DCF¥38.47
Economic Profit¥18.21
Growth Earnings¥29.68

26 of 26 models see the stock below the current price.

Sun Pharmaceutical Industries

DCF Models₹1,182
Earnings-Based₹689
Dividend Discount₹313
Multiples₹878
Asset-Based₹233
Growth DCF₹994
Economic Profit₹588
Growth Earnings₹989

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Jiangsu Hengrui Medicine Co
Bear ¥19.95Fair Value ¥25.94Bull ¥40.28
¥52.11 = current price (white tick)
Sun Pharmaceutical Industries
Bear ₹1,281Fair Value ₹1,781Bull ₹2,431
₹1,951 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Jiangsu Hengrui Medicine Co · Health Care

Quality score59 · Top 25%
Fair value upside-50% · below median

Sun Pharmaceutical Industries · Health Care

Quality score69 · Top 25%
Fair value upside-9% · above median

Bottom line

As of Aug 8, 2026, Fair Value Calculator sees Sun Pharmaceutical Industries as the less overvalued of the two: Jiangsu Hengrui Medicine Co trades at ¥52.11 versus a fair value of ¥25.94 (-50%), while Sun Pharmaceutical Industries trades at ₹1,951 versus ₹1,781 (-9%).

Sun Pharmaceutical Industries has the higher quality score (69/100).

See the full analysis →
Jiangsu Hengrui Medicine Co · Sun Pharmaceutical Industries

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Jiangsu Hengrui Medicine Co

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Sun Pharmaceutical Industries

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.